BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 6779042)

  • 1. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis.
    Williams JC; Gusterson B; Humphreys J; Monaghan P; Coombes RC; Rudland P; Neville AM
    J Natl Cancer Inst; 1981 Jan; 66(1):147-55. PubMed ID: 6779042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability of chemically induced primary rat mammary tumors.
    Dolezalová V; Rejthar A; Sugár J; Tóth J; Vermousek I
    Neoplasma; 1989; 36(1):103-12. PubMed ID: 2495492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to ovariectomy of N-methyl-N-nitrosourea-induced mammary tumors in the rat.
    Turcot-Lemay L; Kelly PA
    J Natl Cancer Inst; 1981 Jan; 66(1):97-102. PubMed ID: 6779043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
    VanderPloeg LC; Wolfrom DM; Welsch CW
    Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic alterations of 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea induced rat mammary tumors during repeated transplantations.
    Dolezalová V; Nĕmecek R; Tóth J; Sugár J
    In Vivo; 1987; 1(4):257-64. PubMed ID: 2979793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-nitrosomethylurea as mammary gland carcinogen in rats.
    Gullino PM; Pettigrew HM; Grantham FH
    J Natl Cancer Inst; 1975 Feb; 54(2):401-14. PubMed ID: 1113323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.
    McCormick DL; Adamowski CB; Fiks A; Moon RC
    Cancer Res; 1981 May; 41(5):1690-4. PubMed ID: 7214338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrous cycle modification of rat mammary tumor induction by a single dose of N-methyl-N-nitrosourea.
    Ratko TA; Beattie CW
    Cancer Res; 1985 Jul; 45(7):3042-7. PubMed ID: 4039975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of isoproterenol on mammary gland tumors induced by N-nitroso-N-methylurea and salivary gland tumors induced by 7,12-dimethylbenz[a]anthracene.
    Barka T
    J Natl Cancer Inst; 1982 Nov; 69(5):1115-20. PubMed ID: 6813551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary tumor induction by N-methyl-N-nitrosourea in genetically resistant Copenhagen rats.
    Lu SJ; Laroye G; Archer MC
    Cancer Res; 1992 Sep; 52(18):5037-41. PubMed ID: 1516059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat.
    Isaacs JT
    Cancer Res; 1986 Aug; 46(8):3958-63. PubMed ID: 3089584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
    Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
    Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of clonal cell lines from a transplantable metastasizing rat mammary tumor, TR2CL.
    Williams JC; Gusterson BA; Monaghan P; Coombes RC; Rudland PS
    J Natl Cancer Inst; 1985 Feb; 74(2):415-28. PubMed ID: 2579259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
    Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
    Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.
    Kang JS; Jung NJ; Kim S; Kim DJ; Jang DD; Yang KH
    Eksp Onkol; 2004 Mar; 26(1):31-5. PubMed ID: 15112577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.